trisodium;phosphate;dodecahydrate

• 分子结构分类: 无机化合物 - 混合金属/非金属化合物 - 碱金属含氧阴离子化合物
• 英文名称: trisodium;phosphate;dodecahydrate
• 化学式: H24Na3O16P
• 分子量: 380.12
• InChiKey: ASTWEMOBIXQPPV-UHFFFAOYSA-K

计算性质

• 辛醇/水分配系数(LogP)：
  -21.71
• 重原子数：
  20
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  98.2
• 氢给体数：
  12
• 氢受体数：
  16

ADMET

毒理性

• 副作用

Dermatotoxin - 皮肤烧伤。

Dermatotoxin - Skin burns.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

反应信息

• 作为反应物：
  描述：

  trisodium;phosphate;dodecahydrate 、 无水氯化钙 在 水 作用下， 以 水 为溶剂， 反应 0.5h， 生成 tricalcium;diphosphate
  参考文献：
  名称：

  RESIN FOR TONER AND TONER

  摘要：

  本发明提供了一种晶体聚酯树脂，具有明显的熔融特性，能够实现固定性能和阻塞性能，并具有优异的开发耐久性，其中用于调色剂的晶体聚酯树脂在25℃下通过超微硬度计测量的杨氏模量至少为2 GPa，熔点至少为60℃且不超过125℃。

  公开号：

  US20160002396A1

文献信息

• Covalently bonded high refractive index particle reagents and their use
  申请人：E. I. Du Pont de Nemours and Company

  公开号：US04401765A1

  公开（公告）日：1983-08-30

  Novel particle reagent for light scattering immunoassays are provided. The particle reagents are high refractive index shell-core polymers covalently bonded to compounds of biological interest. A method of measuring unknown concentrations of these compounds of biological interest by measuring changes in turbidity caused by particle agglutination or its inhibition is also provided.

  提供了一种用于光散射免疫分析的新型粒子试剂。这些粒子试剂是高折射率的壳-核聚合物，与生物感兴趣的化合物共价结合。还提供了一种通过测量由粒子凝聚或其抑制引起的浑浊度变化来测量这些生物感兴趣化合物的未知浓度的方法。
• Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents
  申请人：——

  公开号：US20040235919A1

  公开（公告）日：2004-11-25

  Compounds represented by formula (I), as defined in the description, wherein R is a hydrogen atom or a methyl group and R1 is a group as defined in the specification, or a pharmaceutically acceptable salt thereof, are disclosed; the said compounds are useful in the treatment of cell proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.

  本发明涉及由式(I)所表示的化合物，其中R表示氢原子或甲基基团，R1表示规范中定义的基团或其药学上可接受的盐，这些化合物在治疗与细胞周期依赖性激酶活性改变相关的细胞增殖性疾病，例如癌症方面具有用途。
• Phenylacetamido-pyrazole derivatives and their use as antitumor agents
  申请人：——

  公开号：US20040019046A1

  公开（公告）日：2004-01-29

  Phenylacetamido-pyrazoles and, more particularly, N-(5-cycloalkyl-1H-pyrazol-3-yl)phenylacetamido derivatives, optionally further substituted as reported in the description; or pharmaceutically acceptable salts thereof; are useful in the treatment of cell proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.

  苯乙酰胺基吡唑，更具体地说，是N-(5-环烷基-1H-吡唑-3-基)苯乙酰胺衍生物，可选择性地进一步取代，如描述所述；或其药学上可接受的盐；在治疗与细胞周期依赖性激酶活性改变相关的细胞增殖性疾病，例如癌症方面有用。
• Liquid crystal compounds, liquid crystal medium and liquid crystal display
  申请人：——

  公开号：US20020142108A1

  公开（公告）日：2002-10-03

  The instant invention relates to liquid crystal media comprising a strongly dielectrically positive component A, preferably comprising isothiocyanate compounds, most preferably compounds of formula I, as given in the text, and a further dielectrically positive component B, preferably comprising terminally polar substituted bi- or terphenyl compounds, most preferably comprising compounds of formula II, as given in the text, further to novel isothiocyanato compounds as well as to liquid crystal displays comprising these media, in particular to PDLC display and most particular to holographic PDLC displays. The instant invention further relates to compounds of formula I 1 wherein the parameters are as as specified in the text.

  本发明涉及液晶介质，其中包括强介电正性组分A，优选包括异硫氰酸酯化合物，最优选包括公式I所示的化合物，以及进一步的介电正性组分B，优选包括末端极性取代的双苯或三苯基化合物，最优选包括公式II所示的化合物。本发明还涉及新型异硫氰酸酯化合物，以及包括这些介质的液晶显示器，特别是PDLC显示器，最特别是全息PDLC显示器。本发明还涉及公式I1中参数如文本所述的化合物。
• Calcium phosphate cements comprising amorophous calcium phosphate
  申请人：Norian Corporation

  公开号：US05782971A1

  公开（公告）日：1998-07-21

  Calcium phosphate cements are provided. The subject cements comprise amorphous calcium phosphate, at least one additional calcium source, usually an additional calcium phosphate, and a liquid component, such as a physiologically acceptable lubricant. Upon combination of the cement components, a flowable composition capable of setting in vivo into a solid calcium phosphate mineral product, such as hydroxyapatite, is produced. The subject cement compositions find use in a variety of applications, including the treatment of injured or compromised hard tissue.

  提供了磷酸钙水泥。该水泥包括无定形磷酸钙、至少一种额外的钙源，通常是额外的磷酸钙，以及液体组分，例如生理上可接受的润滑剂。将水泥组分混合后，可产生一种可流动的组合物，在体内凝固成为固态磷酸钙矿物制品，例如羟基磷灰石。该水泥组成物可用于各种应用，包括治疗受伤或受损的硬组织。

表征谱图